EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

A predicting tool for kidney function recovery after drug-induced acute interstitial nephritis

Fernando Caravaca-Fontán iD, Marina Alonso-Riaño, Amir Shabaka iD, Javier Villacorta, Alberto de Lorenzo, Luis F Quintana iD, Eva Rodríguez, Liliana Gadola, María Ángeles Cobo, Aniana Oliet, Milagros Sierra-Carpio, Carmen Cobelo und 4 weitere

Nephrology Dialysis Transplantation · 2025

DOI: 10.1093/ndt/gfaf037 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Fernando Caravaca-Fontán und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain. Hauptthemen laut MEDLINE: Nephritis, Interstitial, Nomograms, Recovery of Function, Acute Kidney Injury. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Instituto Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug-induced acute interstitial nephritis (DI-AIN) represents a common cause of acute kidney injury. Early withdrawal of the culprit drug and corticosteroid therapy remains the mainstay of treatment. This study aimed to develop and validate a predictive nomogram to assess the probability of recovery of kidney function at 6 months after treatment.

Methods

A multicenter, retrospective, observational study was conducted in 13 nephrology departments. Patients with biopsy proven DI-AIN treated with corticosteroids between 1996 and 2023 were included. The dataset was randomly divided into training (n = 164) and validation (n = 60) sets. Least absolute shrinkage and selection operator regression was used to screen the main predictors of complete (creatinine increase <25% of the last value before DI-AIN) or no recovery of kidney function (serum creatinine ≥75% or need for dialysis).

Results

The study group comprised 224 patients with DI-AIN: 51 (31%) in the training group and 19 (32%) in the validation set achieved complete recovery at 6 months. Conversely, 33 (20%) and 8 (13%) patients in the two sets showed no recovery at 6 months. Clinical characteristics were well balanced between training and validation sets. The selected variables were age (under/above 65 years), gender, degree of interstitial fibrosis and time to corticosteroid initiation (under/above 7 days). Based on a multivariable logistic regression model, a nomogram was developed. The area under the curve of the nomogram was 0.79 (95% confidence interval 0.71–0.88), indicating good discriminative power. Bootstrap self-sampling was performed 1000 times for validation of the model. A calibration plot revealed that the predicted outcomes aligned well with the observations. Decision curve analysis suggested that the model had clinical benefit.

Conclusions

We developed and validated a nomogram to predict kidney recovery at 6 months in DI-AIN patients treated with corticosteroids. This tool helps clinicians estimate prognosis and optimize corticosteroid therapy's intensity and duration for better treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephritis, InterstitialNomogramsRecovery of FunctionAcute Kidney InjuryHumansMaleFemaleRetrospective StudiesMiddle AgedPrognosisFollow-Up StudiesKidney Function TestsGlomerular Filtration RateAdultAgedAdrenal Cortex Hormones

Stichwörter der Autor:innen

acute interstitial nephritisdrug-inducedinterstitial fibrosisnomogramrecovery kidney function

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Nephrology, Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.
  • Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Department of Nephrology, Hospital Universitario La Paz, Madrid, Spain.
  • Department of Nephrology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Department of Nephrology, Hospital Universitario de Getafe, Getafe, Spain.
  • Department of Nephrology, Hospital Clínic Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain.

ORCID-Profile: Fernando Caravaca-Fontán, Amir Shabaka, Luis F Quintana, Manuel Praga

Förderung

  • Instituto Carlos III

Zitieren

APA

Caravaca-Fontán, F., Alonso-Riaño, M., Shabaka, A., Villacorta, J., de Lorenzo, A., Quintana, L. F., Rodríguez, E., Gadola, L., Cobo, M. Á., Oliet, A., Sierra-Carpio, M., Cobelo, C., Iglesias, E., Cordón, A., Praga, M., & Fernández-Juárez, G. (2025). A predicting tool for kidney function recovery after drug-induced acute interstitial nephritis. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf037

Vancouver

Caravaca-Fontán F, Alonso-Riaño M, Shabaka A, Villacorta J, de Lorenzo A, Quintana LF, et al. A predicting tool for kidney function recovery after drug-induced acute interstitial nephritis. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfaf037

BibTeX
@article{CaravacaFontn2025,
  author = {Caravaca-Fontán, Fernando and Alonso-Riaño, Marina and Shabaka, Amir and Villacorta, Javier and de Lorenzo, Alberto and Quintana, Luis F and Rodríguez, Eva and Gadola, Liliana and Cobo, María Ángeles and Oliet, Aniana and Sierra-Carpio, Milagros and Cobelo, Carmen and Iglesias, Elena and Cordón, Alfredo and Praga, Manuel and Fernández-Juárez, Gema},
  title = {A predicting tool for kidney function recovery after drug-induced acute interstitial nephritis},
  journal = {Nephrology Dialysis Transplantation},
  year = {2025},
  doi = {10.1093/ndt/gfaf037}
}
Kostenlos starten →